摘  要：医药是人们日常生活的重要的一部分，与人们的身体健康有着密切联系，从改革开放以来，医药行业的发展便稳定增长，隐藏着种种潜力等待各个企业发掘，医药行业的发展正处于黄金时期并已经成为国民经济发展的重要组成部分。在现今的社会中，医药行业发展至今日，市场竞争也十分激烈，企业要想长期稳存在于这个行业，一方面不仅需要强大的融资能力，另一方面还来自企业对自身内部的财务分析，来判断企业是否能够稳定运营，在这个前提下，还要想方设法提高本身的营运能力，企业的资产营运的状况良好,将提高企业资产的使用效率,可以为企业带来更多的收益，发挥财务杠杆作用也能扩大企业的筹资能力和规模，这些都体现了企业是否充分对资源的有效利用。提高企业营运能力对企业的发展具有预测和促进作用,评价企业的营运状况的同时也提高企业的市场竞争力。

本论文以东诚药业集团股份有限公司为研究对象，该公司自1998年开始发展，经过10多年的发展现已经在市场中占领一定地位，近几年，2013年收购烟台大洋制药公司，提高了制剂业务的比重，2015年又成功并购成都云克药业，奠定了公司在中国核医药领域的领先地位，2016年年末及2017年年初东诚药业收购南京江原安迪科公司，上市企业的收购活动对公司前后的财务状况也会有很大影响。本论文以企业营运能力指标为理论依据，收集了东诚药业财务数据，通过流动资产周转率，固定资产周转率，总资产周转率，应收账款周转率和存货周转率等指标，分析全部资产各自的营运能力，评价企业资金周转的情况和资源配置的合理性，对该企业的财务营运过程中全面、正确地评价企业营运能力。

关键词：营运能力；总资产周转率；应收账款周转率；存货周转率

ABSTRACT：Medicine is an important part of people's daily life, closely related to people's health, from the reform and opening up, the development of the pharmaceutical industry will be steady growth, all sorts of hidden potential for various enterprises to explore, the development of the pharmaceutical industry is in a golden period and has become an important part of national economic development. In today's society, the development of the pharmaceutical industry to today, the market competition is very fierce, enterprises want to exist in the long-term stability of the industry, on the one hand needs not only strong financing ability, on the other hand, from the enterprise to internal financial analysis, to determine whether the enterprise can stable operation, in this premise, but also to find ways to improve their operation ability, the assets of the enterprise operating in good condition, will improve the efficiency of the use of corporate assets, can bring more benefits to the enterprise, play the role of financial leverage can also expand their financing capacity and scale, which reflects the enterprise is full of effective utilization of resources. To improve the operation ability of enterprises has the function of predicting and promoting the development of enterprises.

The east Cheng Pharmaceutical Group Limited by Share Ltd as the research object, the company developed since 1998, after 10 years of development now has occupied a certain position in the market, in recent years, the 2013 acquisition of Yantai ocean pharmaceutical company, improve the preparation business proportion, in 2015 the successful acquisition of Chengdu Yunke pharmaceutical company has laid a leading position. China in nuclear medicine, at the end of 2016 and early 2017 East Pharmaceutical acquisition of Nanjing Jiangyuan andike company,The index of enterprise operation ability as the theoretical basis, collection of East Pharmaceutical financial data, the turnover rate of current assets, fixed assets turnover ratio, total assets turnover, accounts receivable turnover and the inventory turnover rate and other indicators, analysis of operating capacity of all assets of the evaluation of enterprise capital turnover situation and resources the configuration of the financial operations of enterprises in the process of the comprehensive and correct evaluation of enterprise operating capacity.